Get the Stockscreener App
0.7818
4.24%
+0.0318
Achilles Therapeutics Plc ADR Stock (ACHL) Forecast
The Achilles Therapeutics Plc ADR (ACHL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.9049, representing a +15.75% increase from the current price of $0.7818. The highest analyst price target is $0.7199, and the lowest is $1.0898.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACHL Price Target
Average 4.1247
(+427.59% Upside)
Is Achilles Therapeutics Plc ADR (ACHL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.25 | Neutral |
| STOCH(9,6) | 24.65 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0855 | Buy |
| ADX(14) | 35.62 | Sell |
| William %R | -65.17 | Neutral |
| CCI(14) | -62.89 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.7764
Buy
|
0.7859
Sell
|
| MA20 |
0.8066
Sell
|
0.8472
Sell
|
| MA50 |
1.0844
Sell
|
0.9572
Sell
|
| MA100 |
0.9953
Sell
|
0.9792
Sell
|
| MA200 |
0.9492
Sell
|
0.9768
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, ACHL could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on ACHL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.25 indicates that ACHL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.65 indicates that ACHL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that ACHL is oversold. This suggests that ACHL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.62 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -62.89 indicates that ACHL is still oversold but not to an extreme extent.
Long-term ACHL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Achilles Therapeutics Plc ADR financial reports and earnings history, Achilles Therapeutics Plc ADR (ACHL) stock could reach $10.58 by 2030, $35.86 by 2040 and $72.68 by 2050. See the projected annual prices until 2050 of the Achilles Therapeutics Plc ADR stock below:
- Achilles Therapeutics Plc ADR (ACHL) is expected to reach an average price of $46.04 in 2035, with a high prediction of $45.43 and a low estimate of $43.10. This indicates an $5,788% rise from the last recorded price of $0.7818.
- Achilles Therapeutics Plc ADR (ACHL) stock is projected to chart a bullish course in 2040, with an average price target of $35.08, representing an $4,387% surge from its current level. The forecast ranges from a conservative $35.31 to a sky-high $35.86.
- Our analysts predict Achilles Therapeutics Plc ADR (ACHL) to jump 919.91% by 2045, soaring from $8.0236 to an average price of $7.9736, potentially reaching $9.5885. While $8.0236 is the low estimate, the potential upside is significant.
- Achilles Therapeutics Plc ADR (ACHL) stock is expected to climb by 2050, reaching an average of $70.96, a $8,977% jump from its current level. However, a wide range of estimates exists, with high and low targets of $72.68 and $71.05, respectively, highlighting the market's uncertainty.
Achilles Therapeutics Plc ADR Stock (ACHL) Year by Year Forecast
Achilles Therapeutics Plc ADR Stock (ACHL) Price Forecast for 2024
Our forecast for ACHL stock price in 2024 now indicates an average price target of $3.4777 with a high forecast of $6.5793 and a low forecast of $0.376. The average prediction reflects an increase of +344.83% from the last recorded price of $0.7818.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.0898 | $1.0898 | $0.7199 | +39.40% |
| July, 2024 | $3.6296 | $1.0258 | $2.9296 | +364.26% |
| August, 2024 | $7.2034 | $6.1455 | $6.5534 | +821.39% |
| September, 2024 | $6.2372 | $6.5072 | $6.5793 | +697.80% |
| October, 2024 | $5.4169 | $6.1791 | $6.281 | +592.88% |
| November, 2024 | $4.5107 | $4.5607 | $3.8588 | +476.97% |
| December, 2024 | $5.5945 | $5.7086 | $4.9665 | +615.60% |
Achilles Therapeutics Plc ADR Stock (ACHL) Price Forecast for 2025
Achilles Therapeutics Plc ADR Stock (ACHL) is expected to reach an average price of $6.2325 in 2025, with a high prediction of $7.303 and a low estimate of $5.162. This indicates an +697.20% rise from the last recorded price of $0.7818.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $6.4443 | $6.8005 | $6.4224 | +724.29% |
| February, 2025 | $6.8481 | $6.1821 | $6.2902 | +775.94% |
| March, 2025 | $7.0119 | $7.00 | $6.9119 | +796.89% |
| April, 2025 | $7.1316 | $7.1916 | $6.9716 | +812.21% |
| May, 2025 | $6.9954 | $7.2554 | $7.2235 | +794.79% |
| June, 2025 | $7.4792 | $7.1473 | $7.0073 | +856.67% |
| July, 2025 | $6.959 | $7.389 | $7.303 | +790.12% |
| August, 2025 | $6.6828 | $6.7728 | $6.8449 | +754.79% |
| September, 2025 | $6.3966 | $6.4766 | $6.4787 | +718.19% |
| October, 2025 | $5.5363 | $6.0863 | $5.9944 | +608.15% |
| November, 2025 | $5.3101 | $5.2982 | $5.2723 | +579.22% |
| December, 2025 | $5.5899 | $5.162 | $5.0861 | +615.00% |
Achilles Therapeutics Plc ADR Stock (ACHL) Price Forecast for 2026
The predicted value for Achilles Therapeutics Plc ADR (ACHL) in 2026 is set at an average of $4.4692. Estimates vary from a peak of $5.8391 to a trough of $3.0993, indicating an +471.65% surge from the present price of $0.7818.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.5237 | $5.5658 | $5.4118 | +606.53% |
| February, 2026 | $5.4075 | $5.6075 | $5.4396 | +591.67% |
| March, 2026 | $5.6613 | $5.2094 | $5.1734 | +624.13% |
| April, 2026 | $5.411 | $5.501 | $5.8391 | +592.12% |
| May, 2026 | $5.0948 | $5.1148 | $5.307 | +551.68% |
| June, 2026 | $4.8986 | $4.9036 | $4.9567 | +526.58% |
| July, 2026 | $4.6709 | $4.7684 | $4.7746 | +497.45% |
| August, 2026 | $4.5022 | $4.562 | $4.5794 | +475.87% |
| September, 2026 | $3.9619 | $4.0011 | $4.3581 | +406.77% |
| October, 2026 | $3.7057 | $3.7057 | $3.8479 | +374.00% |
| November, 2026 | $3.2595 | $3.3895 | $3.5717 | +316.92% |
| December, 2026 | $3.058 | $3.0993 | $3.1855 | +291.15% |
Achilles Therapeutics Plc ADR Stock (ACHL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Achilles Therapeutics Plc ADR (ACHL) is $7.2425, with a high forecast of $14.42 and a low forecast of $0.0652. This indicates an +826.39% increase from the last price of $0.7818.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.8381 | $2.8671 | $2.9652 | +263.02% |
| February, 2027 | $2.5593 | $2.5727 | $2.7192 | +227.36% |
| March, 2027 | $2.1733 | $2.2046 | $2.4288 | +177.99% |
| April, 2027 | $1.9144 | $1.9303 | $2.0487 | +144.87% |
| May, 2027 | $1.6239 | $1.6356 | $1.8164 | +107.71% |
| June, 2027 | $1.114 | $1.254 | $1.4802 | +42.49% |
| July, 2027 | $0.7178 | $0.8677 | $1.0374 | -8.19% |
| August, 2027 | $0.2516 | $0.2456 | $0.2737 | -67.82% |
| September, 2027 | $0.2613 | $0.0994 | $0.2473 | -66.58% |
| October, 2027 | $0.1213 | $0.0652 | $0.1774 | -84.49% |
| November, 2027 | $13.82 | $12.85 | $13.29 | +1,668% |
| December, 2027 | $14.64 | $14.65 | $14.42 | +1,773% |
Achilles Therapeutics Plc ADR Stock (ACHL) Price Forecast for 2028
In 2028, Achilles Therapeutics Plc ADR (ACHL) is projected to reach an average price of $17.64, with a high projection of $19.59 and a low estimate of $15.68. This indicates an +2,156% rise from the last price of $0.7818.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.96 | $15.68 | $16.26 | +2,069% |
| February, 2028 | $20.24 | $19.40 | $19.59 | +2,488% |
| March, 2028 | $18.55 | $18.97 | $19.54 | +2,272% |
| April, 2028 | $17.78 | $18.77 | $18.72 | +2,175% |
| May, 2028 | $17.26 | $16.63 | $16.38 | +2,108% |
| June, 2028 | $18.44 | $17.56 | $17.20 | +2,259% |
| July, 2028 | $17.85 | $18.30 | $17.97 | +2,183% |
| August, 2028 | $18.00 | $17.36 | $17.62 | +2,202% |
| September, 2028 | $17.89 | $17.96 | $17.76 | +2,188% |
| October, 2028 | $17.57 | $17.63 | $17.52 | +2,148% |
| November, 2028 | $17.20 | $17.29 | $17.52 | +2,100% |
| December, 2028 | $17.09 | $17.12 | $17.00 | +2,086% |
Achilles Therapeutics Plc ADR Stock (ACHL) Price Forecast for 2029
The 2029 price forecast for Achilles Therapeutics Plc ADR Stock (ACHL) is $13.84 on average, with a high prediction of $16.87 and a low estimate of $10.80. This represents an +1,670% increase from the previous price of $0.7818.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $16.25 | $16.49 | $16.87 | +1,979% |
| February, 2029 | $15.83 | $15.96 | $16.08 | +1,924% |
| March, 2029 | $14.90 | $15.16 | $15.46 | +1,805% |
| April, 2029 | $14.05 | $14.60 | $14.66 | +1,697% |
| May, 2029 | $13.37 | $13.44 | $13.71 | +1,610% |
| June, 2029 | $13.44 | $13.23 | $12.89 | +1,619% |
| July, 2029 | $13.08 | $13.29 | $13.11 | +1,573% |
| August, 2029 | $12.47 | $12.60 | $12.92 | +1,495% |
| September, 2029 | $12.92 | $12.32 | $12.45 | +1,553% |
| October, 2029 | $11.86 | $11.93 | $12.65 | +1,418% |
| November, 2029 | $11.27 | $11.32 | $11.70 | +1,342% |
| December, 2029 | $10.78 | $10.80 | $11.10 | +1,279% |
Achilles Therapeutics Plc ADR Stock (ACHL) Price Forecast for 2030
Achilles Therapeutics Plc ADR Stock (ACHL) is expected to reach an average price of $6.9545 in 2030, with a high forecast of $10.58 and a low forecast of $3.3279. This signifies an +789.55% surge from the last price of $0.7818.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.17 | $10.21 | $10.58 | +1,201% |
| February, 2030 | $9.6287 | $9.7005 | $9.9855 | +1,132% |
| March, 2030 | $8.9238 | $8.963 | $9.3181 | +1,041% |
| April, 2030 | $8.3714 | $8.3714 | $8.7357 | +970.79% |
| May, 2030 | $7.5509 | $7.5809 | $8.1633 | +865.84% |
| June, 2030 | $7.0573 | $7.0985 | $7.3928 | +802.70% |
| July, 2030 | $6.3705 | $6.4365 | $6.8904 | +714.85% |
| August, 2030 | $5.7616 | $5.85 | $6.1634 | +636.97% |
| September, 2030 | $5.2099 | $5.2412 | $5.4775 | +566.40% |
| October, 2030 | $4.5117 | $4.5227 | $5.0052 | +477.09% |
| November, 2030 | $3.8513 | $3.9503 | $4.2094 | +392.62% |
| December, 2030 | $3.1879 | $3.3279 | $3.7022 | +307.77% |
3.18%
Cap:
|
Volume (24h):